Tuffclassified

India’s pharmaceutical industry is changing fast. Patients are more informed. Regulators expect stronger proof. Healthcare systems are focusing on outcomes, not just approvals. In this evolving landscape, clinical trials alone are no longer enough. They show how drugs work in controlled settings, but not how they perform in real life. This is where Real-world studies are gaining importance. These studies capture data from everyday clinical practice and reflect how treatments work across diverse patient populations. In a country as complex as India, this kind of insight is critical. As a result, Real World Evidence Studies are becoming a key pillar of India’s pharmaceutical ecosystem.